Cargando…

Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension

The renin-angiotensin system (RAS) is an important regulator of cirrhosis and portal hypertension. As hepatic fibrosis progresses, levels of the RAS components angiotensin (Ang) II, Ang-(1–7), angiotensin-converting enzyme (ACE), and Ang II type 1 receptor (AT1R) are increased. The primary effector...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shim, Kwang Yong, Eom, Young Woo, Kim, Moon Young, Kang, Seong Hee, Baik, Soon Koo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943664/ https://www.ncbi.nlm.nih.gov/pubmed/29462546 http://dx.doi.org/10.3904/kjim.2017.317

Ejemplares similares

Mesenchymal stem cell therapy for liver fibrosis
por: Eom, Young Woo, et al.
Publicado: (2015)

Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options
por: Rajapaksha, Indu G., et al.
Publicado: (2021)

Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
por: Eom, Young Woo, et al.
Publicado: (2019)

Hemodynamic alterations in cirrhosis and portal hypertension
por: Kim, Moon Young, et al.
Publicado: (2010)

Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis
por: Kim, Gaeun, et al.
Publicado: (2017)

The Role of the Renin-Angiotensin System in Hepatic Fibrosis
por: Lubel, J.S., et al.
Publicado: (2007)

Recent Update of Renin-angiotensin-aldosterone System in the Pathogenesis of Hypertension
por: Moon, Ju-Young
Publicado: (2013)

Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives
por: Kang, Seong Hee, et al.
Publicado: (2020)

Perspectives on Acute Hepatitis A Control in Korea
por: Kang, Seong Hee, et al.
Publicado: (2019)

Mesenchymal stem cells to treat liver diseases
por: Eom, Young Woo, et al.
Publicado: (2020)

Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease
por: Hong, Won Ki, et al.
Publicado: (2014)

Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis
por: Lim, Yoo Li, et al.
Publicado: (2016)

Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data
por: Kim, Hyung Ki, et al.
Publicado: (2014)

The Accuracy of Ultrasonography for the Evaluation of Portal Hypertension in Patients with Cirrhosis: A Systematic Review
por: Kim, Gaeun, et al.
Publicado: (2015)

Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis
por: Cho, Eun Ju, et al.
Publicado: (2015)

Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score
por: Kang, Seong Hee, et al.
Publicado: (2018)

Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
por: Kang, Seong Hee, et al.
Publicado: (2022)

Expression of Fibroblast Growth Factor 21 and β-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-κB and c-Jun N-Terminal Kinase Pathways
por: Lee, Kyong Joo, et al.
Publicado: (2018)

Renin-Angiotensin System - Considerations for Hypertension and Kidney
por: Yim, Hyung Eun, et al.
Publicado: (2008)

Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis
por: Jang, Yoon Ok, et al.
Publicado: (2015)

Effects of Resveratrol on the Renin-Angiotensin System in the Aging Kidney
por: Jang, In-Ae, et al.
Publicado: (2018)

The renin-angiotensin system and aging in the kidney
por: Yoon, Hye Eun, et al.
Publicado: (2014)

Role of the central renin-angiotensin system in hypertension (Review)
por: Su, Chuanxin, et al.
Publicado: (2021)

The association of renin–angiotensin system blockades and pneumonia requiring admission in patients with COPD
por: Kim, Junghyun, et al.
Publicado: (2016)

Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis
por: Kim, Gaeun, et al.
Publicado: (2017)

Generation of Fibrotic Liver Organoids Using Hepatocytes, Primary Liver Sinusoidal Endothelial Cells, Hepatic Stellate Cells, and Macrophages
por: Yoon, Yongdae, et al.
Publicado: (2023)

Chronic Activation of the Renin-Angiotensin System Induces Lung Fibrosis
por: Wang, Jiaolong, et al.
Publicado: (2015)

Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis
por: Zhu, Qianqian, et al.
Publicado: (2016)

Nanoparticle approaches for the renin-angiotensin system
por: Hettiarachchi, Sajini D., et al.
Publicado: (2023)

The Impact of Sarcopenia and Its Rate of Change on Prognostic Value of Liver Cirrhosis
por: Kang, Seong Hee, et al.
Publicado: (2018)

Application of Baveno Criteria and Modified Baveno Criteria with Shear-wave Elastography in Compensated Advanced Chronic Liver Disease
por: Kang, Seong Hee, et al.
Publicado: (2020)

Age-Associated Changes in the Vascular Renin-Angiotensin System in Mice
por: Yoon, Hye Eun, et al.
Publicado: (2016)

Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats
por: Hsu, Shao-Jung, et al.
Publicado: (2020)

GENETIC INFLUENCE ON THE RENIN-ANGIOTENSIN SYSTEM : EVIDENCE FOR A RENIN INHIBITOR IN HYPERTENSION-PRONE RATS
por: Iwai, Junichi, et al.
Publicado: (1970)

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
por: Kim, Jae Hyun, et al.
Publicado: (2014)

Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
por: Kang, Si-Hyuck, et al.
Publicado: (2021)

Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension
por: Chen, Jiegen, et al.
Publicado: (2020)

Translational studies on augmentation of intratubular renin–angiotensin system in hypertension
por: Navar, L Gabriel
Publicado: (2013)

Vaccine Development against the Renin-Angiotensin System for the Treatment of Hypertension
por: Azegami, Tatsuhiko, et al.
Publicado: (2019)

Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19
por: Williams, Bryan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_73q7cvps4f3s4imdm7bs9apq2q